IP Library Patent Application 10833088
Patent Application
App. No. 10/833,088

Cephem compounds

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/833,088
Abstract

The present invention relates to a compound of the formula [I]: wherein R 1 is lower alkyl which may have suitable substituent(s), R 2 is amino, protected amino or guanidino, R 3 is carboxy or protected carboxy, R 4 is amino or protected amino, and A is lower alkylene, or a pharmaceutically acceptable salt thereof, a process for preparing a compound of the formula [I], and a pharmaceutical composition comprising a compound of the formula [I] in admixture with a pharmaceutically acceptable carrier.

Claims (30)

1 . A compound of the formula [I]:

wherein

R 1 is lower alkyl which may have suitable substituent(s),

R 2 is amino, protected amino or guanidino,

R 3 is carboxy or protected carboxy,

R 4 is amino or protected amino, and

A is lower alkylene,

or a pharmaceutically acceptable salt thereof.

2 . A process for preparing a compound of the formula [I]:

wherein

R 1 is lower alkyl which may have suitable substituent(s),

R 2 is amino, protected amino or guanidino,

R 3 is carboxy or protected carboxy,

R 4 is amino or protected amino, and

A is lower alkylene,

or a salt thereof, which comprises

(1) reacting a compound of the formula [II]:

wherein R 1 , R 2 and A are each as defined above, or its reactive derivative at the amino group, or a salt thereof with a compound of the formula [III]:

wherein R 3 and R 4 are each as defined above, or its reactive derivative at the carboxy group, or a salt thereof to give a compound of the formula [I]:

wherein R 1 , R 2 , R 3 , R 4 and A are each as defined above, or a salt thereof, or

(2) reacting a compound of the formula [VI]:

wherein R 3 and R 4 are each as defined above, R 5 is protected carboxy, and Y is a leaving group, or a salt thereof with a compound of the formula [VII]:

wherein R 1 , R 2 and A are each as defined above, or a salt thereof to give a compound of the formula [VIII]:

wherein R 1 , R 2 , R 3 , R 4 , R 5 and A are each as defined above, and X {circle over (−)} is an anion, or a salt thereof, and subjecting the compound of the formula [VIII] or a salt thereof to elimination reaction of the carboxy protecting group, to give a compound of the formula [I]:

wherein R 1 , R 2 , R 3 , R 4 and A are each as defined above, or a salt thereof.

3 . A pharmaceutical composition comprising a compound of claim 1 or a pharmaceutically acceptable salt thereof in admixture with a pharmaceutically acceptable carrier.

4 . A compound of claim 1 or a pharmaceutically acceptable salt thereof for use as a medicament.

5 . A compound of claim 1 or a pharmaceutically acceptable salt thereof for use as an antimicrobial agent.

6 . Use of a compound of claim 1 or a pharmaceutically acceptable salt thereof for manufacture of a medicament for treating infectious diseases.

7 . A method for the treatment of infectious diseases which comprising administering a compound of claim 1 or a pharmaceutically acceptable salt thereof to human or animals.

Assignments (2)
MERGER Recorded Dec 12, 2005
From: FUJISAWA PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 017073/0257 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2004
From: YAMANAKA, TOSHIO; OHKI, HIDENORI; OHGAKI, MASARU; OKUDA, SHINYA; TODA, AYAKO; KAWABATA, KOHJI; INOUE, SATOSHI; MISUMI, KEIJI; ITOH, KENJI; SATOH, KENJI
To: FUJISAWA PHARMACEUTICAL CO., LTD.; WAKUNAGA PHARMACEUTICAL CO., LTD.
Reel/Frame 015757/0333 →